Article History
Received: 1 December 2018
Accepted: 7 February 2019
First Online: 4 March 2019
Compliance with ethical standards
:
: H.F. received lecture fees from Chugai Pharmaceutical Co., Ltd., Bayer Yakuhin Co., Ltd., KISSEI Pharmaceutical Co., Ltd., and ONO Pharmaceutical Co., Ltd., and scholarship/donation from Chugai Pharmaceutical Co., Ltd., Bayer Yakuhin Co., Ltd. and ONO Pharmaceutical Co., Ltd., MSD, Asteras, TEIJIN and KYOWA HAKKO KIRIN Pharmaceutical Co., Ltd. S.N. received lecture fees from Chugai Pharmaceutical Co., Ltd., Bayer Yakuhin Co., Ltd., KYOWA HAKKO KIRIN Pharmaceutical Co., and Asteras Pharmaceutical Co., Ltd., and scholarship/donation from Chugai Pharmaceutical Co., Ltd., Bayer Yakuhin Co., Ltd., and ONO Pharmaceutical Co., Ltd., MSD, Asteras, TEIJIN and KYOWA HAKKO KIRIN Pharmaceutical Co., Ltd. All other authors declared no other conflict of interest.
: Not applicable.
: Not applicable. Contents of this manuscript were partly presented as the Clinical Scientist Award memorial lecture at the 61th annual meeting of the Japanese Society of Nephrology, 2018.